Cutler Group LP Atea Pharmaceuticals, Inc. Call Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 04, 2022	SELL	$5.33 - $8.18 $22,386 - $34,356	-4,200 Reduced 62.69%	2,500 $0
Q1 2022 Apr 14, 2022	SELL	$5.5 - $9.19 $137,500 - $229,750	-25,000 Reduced 78.86%	6,700 $0
Q4 2021 Jan 18, 2022	BUY	$7.67 - $44.59 $223,964 - $1.3 Million	29,200 Added 1168.0%	31,700 $12,000
Q3 2021 Oct 26, 2021	BUY	$21.33 - $35.06 $44,793 - $73,626	2,100 Added 525.0%	2,500 $9,000
Q2 2021 Jul 19, 2021	BUY	$19.22 - $59.08 $7,688 - $23,632	400 New	400 $0

112

52.4M

900

126K

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $281M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.